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Daydreamer, a Ras effector and GSK-3 substrate, 
is important for directional sensing and cell 
motility
Verena Kölscha,*, Zhouxin Shena, Susan Leea, Katarzyna Plakb, Pouya Lotfia, Jessica Changa, 
Pascale G. Charesta,c, Jesus Lacal Romeroa, Taeck J. Jeona,†, Arjan Kortholtb, Steven P. Briggsa, 
and Richard A. Firtela,c
aSection of Cell and Developmental Biology, Division of Biological Sciences, University of California, San Diego, 
La Jolla, CA 92093-0380; bDepartment of Molecular Cell Biology, University of Groningen, 9751 NN Haven, The 
Netherlands; cUniversity of Arizona, Department of Chemistry and Biochemistry, Tucson, AZ 85721-0088
ABSTRACT How independent signaling pathways are integrated to holistically control a bio-
logical process is not well understood. We have identified Daydreamer (DydA), a new mem-
ber of the Mig10/RIAM/lamellipodin (MRL) family of adaptor proteins that localizes to the 
leading edge of the cell. DydA is a putative Ras effector that is required for cell polarization 
and directional movement during chemotaxis. dydA− cells exhibit elevated F-actin and as-
sembled myosin II (MyoII), increased and extended phosphoinositide-3-kinase (PI3K) activity, 
and extended phosphorylation of the activation loop of PKB and PKBR1, suggesting that 
DydA is involved in the negative regulation of these pathways. DydA is phosphorylated by 
glycogen synthase kinase-3 (GSK-3), which is required for some, but not all, of DydA’s func-
tions, including the proper regulation of PKB and PKBR1 and MyoII assembly. gskA− cells 
exhibit very strong chemotactic phenotypes, as previously described, but exhibit an in-
creased rate of random motility. gskA− cells have a reduced MyoII response and a reduced 
level of phosphatidylinositol (3,4,5)-triphosphate production, but a highly extended recruit-
ment of PI3K to the plasma membrane and highly extended kinetics of PKB and PKBR1 
activation. Our results demonstrate that GSK-3 function is essential for chemotaxis, regulat-
ing multiple substrates, and that one of these effectors, DydA, plays a key function in the 
dynamic regulation of chemotaxis.
INTRODUCTION
Chemotaxis, or directed cell movement up a chemoattractant gradi-
ent, plays a key role in a range of biological processes, including 
innate immunity, metastasis of cancer cells, tissue development, 
food foraging, and the formation of multicellular structures in free-
living organisms such as Dictyostelium (Eccles, 2004; Martin and 
Parkhurst, 2004; Böttcher and Niehrs, 2005; Sasaki and Firtel, 2006). 
Cells are able to sense extracellular gradients as shallow as a 2% 
difference in chemoattractant concentration across the cell and are 
able to amplify that gradient intracellularly to produce a highly 
polarized cell in which the activity of leading edge– and posterior-
specific signaling components are highly restricted to the respective 
poles of the cell (Van Haastert and Veltman, 2007; Janetopoulos and 
Firtel, 2008; Kölsch et al., 2008). The Ras family of small GTPases, 
including Ras and Rap1, are key upstream regulators of directional 
sensing and chemotaxis. Dictyostelium cells in which Ras function 
has been abrogated exhibit delayed polarization when placed in a 
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that act downstream of Ras-like GTPases and translate extracellu-
lar signals into changes of the actin cytoskeleton affecting cell mo-
tility and adhesion (Krause et al., 2004; Lafuente et al., 2004; 
Chang et al., 2006; Lyulcheva et al., 2008). Like other MRL pro-
teins, DDB_G0287875 has an N-terminal RA domain, followed by 
a pleckstrin homology (PH) domain and a proline-rich motif (PRM). 
In addition, DDB_G0287875 has two calponin homology (CH) do-
mains (Friedberg and Rivero, 2009) and a second RA domain at the 
C-terminus. On the basis of the chemotactic defects of the DDB_
G0287875 null strain described below, we have named the protein 
Daydreamer, or DydA.
To determine whether DydA plays a role in chemotaxis, we gen-
erated dydA− cells by homologous recombination and analyzed the 
chemotactic properties of these cells. dydA− cells exhibit strong 
chemotactic defects: when placed in a strong chemoattractant gra-
dient emitted by a micropipette, dydA− cells polarize weakly, move 
with reduced speed and deeply reduced directionality, and have 
more lateral filopodia (Figure 1, B–D, and Supplemental Movies S1 
and S2). In shallow, linear gradients produced in a Dunn chamber, 
the cells do not move (as noted in Figure 3C, which appears later in 
this article). The low, measured speed results from jiggling of the 
cells, which results in a change in the location of the cell’s centroid. 
Because of the slow, more random, and lackadaisical “pace” of 
chemotaxis, we named the gene daydreamer (dydA).
Tagged DydA complements the dydA− cell chemotactic defects 
and DydA–green fluorescent protein (DydA-GFP) localizes to the 
leading edge of chemotaxing and randomly moving cells (Figure 1, 
C and E), suggesting that DydA is involved in leading-edge signal-
ing. GFP-DydA also transiently localizes from the cytosol to the 
plasma membrane in response to uniform (global) chemoattractant 
stimulation with peak localization at ∼7–9 s (Figure 1F). Pretreatment 
with latrunculin B, an inhibitor of F-actin polymerization, results in a 
high basal level of DydA at the cortex with no additional recruitment 
upon chemoattractant stimulation, suggesting that F-actin plays a 
role in regulating DydA’s cortical localization (Figure 1G). dydA− cells 
exhibit a very elevated and extended first and second peak of 
F-actin polymerization and an extended and highly elevated second 
peak (Figure 1H). The level of assembled MyoII is elevated ∼40% in 
unstimulated cells and, upon chemoattractant stimulation, the kinet-
ics of MyoII are similar to those of wild-type cells (Figure 1I). These 
findings indicate that DydA plays a role in negatively regulating 
F-actin polymerization and MyoII assembly.
dydA− cells exhibit an extended and highly elevated plasma 
membrane localization of the PI(3,4,5)P3 reporter PHcrac in response 
to chemoattractant stimulation (Figure 2A), suggesting that PI3K ac-
tivity is elevated and extended. As elevated levels of PIP3 can result 
in dominant, gain-of-function phenotypes that result in multiple 
pseudopod formation, we tested whether addition of the PI3K in-
hibitor LY294002 suppressed the dydA− chemotactic phenotype 
and found that it did not (unpublished data). We also examined the 
regulation and activity of Akt/PKB and the related enzyme PKBR1, 
both of which play key roles in regulating leading-edge function 
during chemotaxis (Meili et al., 1999, 2000; Kamimura et al., 2008). 
Akt/PKB and PKBR1 are activated at the plasma membrane by two 
phosphorylations, as are mammalian Akt/PKBs (Sarbassov et al., 
2005): the ALs are phosphorylated by the two PDK1 isoforms, PdkA 
and PdkB (Kamimura et al., 2008; Liao et al., 2010), while TORC2 
phosphorylates the conserved hydrophobic motif (HM) of Akt/PKB 
and PKBR1 (Lee et al., 2005; Kamimura et al., 2008; Cai et al., 2010; 
Liao et al., 2010). Chemoattractant-mediated plasma membrane lo-
calization of Akt/PKB is mediated through the binding of the PH 
domain of Akt/PKB to the PI3K product PI(3,4,5)P3 (Meili et al., 1999; 
chemoattractant gradient and, once polarized, move randomly, be-
ing unable to sense the direction of the gradient (Sasaki et al., 2004). 
Proper spatiotemporal regulation of at least two Ras-mediated 
pathways is required in Dictyostelium for efficient directed migra-
tion: the class 1 phosphoinositide-3-kinase (PI3K) pathway, which is 
activated predominantly by RasG, and the target of rapamycin com-
plex 2 (TORC2) pathway, which is activated predominantly by RasC 
(Lee et al., 1999; Funamoto et al., 2002; Sasaki et al., 2004, 2007; 
Sasaki and Firtel, 2006; Bolourani et al., 2006; Charest et al., 2010). 
PI3K and TORC2 lead to the local activation of Akt/PKB and the re-
lated kinase PKBR1 and other downstream effectors, resulting in 
changes in the cytoskeleton and directed migration (Kamimura 
et al., 2008; Kamimura and Devreotes, 2010; Charest et al., 2010). 
Efficient chemotaxis has also been shown to require additional Ras 
and Rap1 effectors, signaling from guanylyl cyclase and phospholi-
pase A2, and, more recently, glycogen synthase kinase-3 (GSK-3; 
Veltman and Van Haastert, 2006; Veltman et al., 2008; van Haastert 
et al., 2007; Chen et al., 2007; Teo et al., 2010; Kim et al., 2011).
GSK-3, identified in mammalian cells as a kinase that phosphory-
lates and regulates glycogen synthase, controls a wide range of bio-
logical processes, including insulin and Wnt signaling, cell survival, 
neuronal development, and cell migration (Embi et al., 1980; 
Hemmings et al., 1981; Cross et al., 1995; Pap and Cooper, 1998; 
Papkoff and Aikawa, 1998; Kozlovsky et al., 2002; Manoukian and 
Woodgett, 2002; reviewed in Jope and Johnson, 2004; Kim et al., 
2009). Dictyostelium GSK-3 was discovered in a genetic screen for 
regulators of cell fate determination (Harwood et al., 1995; Kawata 
et al., 1997; Ginger et al., 2000; Grimson et al., 2000) and subse-
quently demonstrated to be required for chemotaxis (Teo et al., 
2010; Kim et al., 2011). GSK-3–null (gskA−) cells move more slowly 
and have a deeply decreased directionality when compared with 
wild-type cells (Teo et al., 2010; Kim et al., 2011). gskA− cells were 
reported to have reduced production of the PI3K product phos-
phatidylinositol (3,4,5)-triphosphate (PI(3,4,5)P3) and reduced phos-
phorylation of the activation loop (AL) of Akt/PKB and the related 
kinase PKBR1 (Teo et al., 2010).
To obtain more insight into the mechanisms by which Ras and 
Rap1 control chemotaxis, we performed a bioinformatics screen for 
proteins with potential Ras/Rap1 binding domains and identified 
Daydreamer (DydA), a member of the Mig10/RIAM/lamellipodin 
(MRL) family of adaptor proteins, as a new Ras/Rap1 effector. We 
show that DydA localizes to the leading edge of chemotaxing cells 
and plays key roles in regulating both F-actin polymerization and 
myosin II (MyoII) assembly, in part by regulating the kinetics of Akt/
PKB and the related enzyme PKBR1. We found that DydA binds 
RasG-GTP and is phosphorylated by GSK-3 and that this phospho-
rylation is required for some of DydA’s functions. Through a detailed 
analysis of the gskA− cell chemotactic phenotype, we demonstrate 
that the kinetics and levels of the activities of Ras, Akt/PKB, and 
PKBR1 are misregulated in gskA− cells. These studies link the Ras 
and GSK-3 signaling networks through the protein DydA and pro-
vide insights into how these networks regulate directional sensing 
and chemotaxis.
RESULTS
Daydreamer (DDB_G0287875) is required 
for proper chemotaxis
DDB_G0287875 was identified in a bioinformatics search of the 
Dictyostelium database for proteins that have Ras-association (RA) 
domains and thus represented a new, potential Ras and/or Rap1 
effector. From its domain structure (Figure 1A), DDB_G0287875 
appears to be a member of the MRL family of adaptor proteins 
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FIGURE 1: dydA− cells exhibit chemotactic defects. (A) Domain structure of DDB_G0287875/Daydreamer. RA, Ras 
association domain; PH, pleckstrin homology domain; CH, calponin homology domain; PRM, proline-rich motif; S861 and 
T865, phosphorylated residues. (B) Live imaging of chemotaxing wild-type and dydA- cells. The source of the 
chemoattractant is located in the lower left corner of the images; images are at 5-min intervals over a 30-min time 
frame. (C) DIAS analysis of wild-type cells, dydA− cells, and dydA− cells expressing DydA-HHF chemotaxing toward a 
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specific activity of Akt/PKB kinase activity is similar to that in wild-
type cells, the total level of Akt/PKB protein and kinase activity is 
∼50% that of wild-type cells. The greatest effect of dydA− cells is on 
the AL phosphorylation of Akt/PKB, consistent with elevated levels 
of PI(3,4,5)P3 activity.
Role of the RA domains in controlling DydA function
The small GTPases Ras and Rap1 are major regulators of chemot-
axis and lie upstream from PI3K and TORC2 (Lee et al., 1999; 
Funamoto et al., 2002; Sasaki et al., 2004, 2007; Sasaki and Firtel, 
2006; Bolourani et al., 2006, 2008; Charest et al., 2010). As DydA 
has two RA domains, we examined the possible role of DydA on the 
Funamoto et al., 2002), while PKBR1 is constitutively localized on 
the plasma membrane through an N-terminal myristoyl group and 
does not require either PI3K activity or PI(3,4,5)P3 binding for its 
activation (Meili et al., 2000; Lee et al., 2005; Kamimura et al., 2008). 
In wild-type cells, under our experimental conditions, the AL and 
HM phosphorylation of Akt/PKB and PKBR1 peak at ∼10 s after 
chemoattractant stimulation, consistent with the peak of kinase ac-
tivity (Figure 2, B–E; quantitation of the data in Figure 2, B and C, is 
presented in Supplemental Figure S1A; Meili et al., 1999, 2000; Lee 
et al., 2005). In dydA− cells, we observe that the HM phosphoryla-
tion is elevated for Akt/PKB and PKBR1 and that the phosphoryla-
tion of the AL is elevated and extended. Although the relative 
FIGURE 2: Lack of DydA affects Ras effector pathways. (A) Translocation kinetics of PHcrac-GFP in dydA− cells in 
response to cAMP stimulation. Data represent mean ± SE of relative fluorescence intensity of membrane-localized 
PHcrac-GFP as a function of time after cAMP stimulation with the starting condition taken as 1.0. (B and C) 
Phosphorylation of the HM and AL, respectively, of Akt/PKB and PKBR1 in wild-type and dydA− cells in response to 
cAMP. Coomassie Blue staining was used as loading control. (D and E) cAMP-induced Akt/PKB and PKBR1 kinase 
activity, respectively. H2B was used as substrate; protein levels were determined by immunoblotting and silver staining 
was used as loading control; for quantification, the maximum value of wild-type cells was taken as 1.0; data are mean ± 
SE of at least three independent experiments. (F) Ras activation in dydA− cells. cAMP-induced Ras activation was 
assessed using RBDRaf1 and RBDByr2 in pull-down assays; levels of total Ras and Ras-GTP were analyzed with panRas 
immunoblotting and quantified, with the maximum value of wild-type cells was taken as 1.0; data are mean ± SD of at 
least three independent experiments.
micropipette emitting cAMP. Data represent mean ± SD; speed indicates the speed of the cells’ centroid movement 
along the total path; directionality indicates the linearity of the migration paths; direction change is a relative measure 
of the number and frequency of turns of the cells; roundness is a measure of the polarization of the cells. (D) F-actin 
localization in wild-type and dydA− aggregation-competent (developed) cells using fluorescent phalloidin. Scale bar: 
10 μm. (E) Localization of DydA-GFP in vegetative randomly moving cells and aggregation-competent chemotaxing 
cells. Asterisk indicates the chemoattractant source. (F) Translocation kinetics of DydA-GFP and DydAΔRA1+2-GFP in 
response to cAMP stimulation. The data represent the mean ± SE of relative fluorescence intensity of membrane-
localized DydA-GFP as a function of time after cAMP stimulation with the starting condition taken as 1.0. 
(G) Translocation kinetics of DydA-GFP in response to cAMP stimulation after latrunculin B treatment. The data 
represent the mean ± SE of relative fluorescence intensity of membrane-localized DydA-GFP as a function of time after 
cAMP stimulation, with the starting condition taken as 1.0. (H) cAMP-induced F-actin polymerization. Data represent 
mean ± SE of at least three independent experiments, with the starting condition in wild-type cells taken as 1.0. 
(I) cAMP-induced MyoII assembly. Data represent mean ± SE of at least three independent experiments, with the 
starting condition in wild-type cells taken as 1.0.
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expressing DydAΔRA1+2-HHF, we found that both peaks of F-actin 
polymerization are reduced compared with wild-type cells and that 
the first peak of actin decreases much faster than in wild-type cells 
(Figure 3D). This suggests that DydAΔDRA1+2 inhibits F-actin 
polymerization and facilitates F-actin depolymerization. We also 
found that MyoII assembly is dramatically reduced in dydA−/
DydAΔRA1+2 cells compared with wild-type cells (Figure 3E). These 
findings were unexpected, as dydA− cells show elevated basal levels 
of assembled MyoII but normal kinetics and levels of chemoattrac-
tant-mediated assembly, suggesting that DydAΔRA1+2, directly 
or indirectly, inhibits MyoII assembly and F-actin polymerization. 
In addition, we found that the phosphorylations of the HM and 
AL sites of Akt/PKB and PKBR1 are extended, as is the case for 
dydA− cells (Figure 3, F and G, and quantitation in Figure S1A). 
DydAΔRA1+2-GFP localizes to the leading edge of chemotaxing 
cells (Movie S3). Interestingly, DydAΔRA1+2-GFP exhibits a highly 
elevated level of cortical localization upon chemoattractant stimula-
tion but with response kinetics similar to those of wild-type cells 
(Figure 1F). These observations, together with the fact that the activ-
ity of Ras and Rap1 is not severely altered in dydA− cells, suggest 
that DydA might act as a downstream effector of Ras that directly or 
indirectly regulates F-actin polymerization and MyoII assembly. Fur-
thermore, the RA domains are required for modulating the regula-
tion of DydA function but not its localization per se.
The CH domains and the PRM, but not the PH domain, 
are involved in localizing DydA to the leading edge
The MRL family member lamellipodin is recruited to the leading 
edge of fibroblasts upon platelet-derived growth factor (PDGF) 
stimulation through the interaction of its PH domain with phosphati-
dylinositol (3,4)-bisphosphate (PI(3,4)P2; Krause et al., 2004). As 
DydA localizes to the leading edge of chemotaxing Dictyostelium 
cells, we tested whether this localization requires the PH domain of 
DydA. We found that DydAΔPH-GFP still localizes to the leading 
edge of migrating cells, translocates to the membrane upon global 
stimulation with kinetics similar to DydA-GFP, and complements the 
dydA− cells’ chemotactic phenotypes, indicating the PH domain is 
not required (Figures 3, H and I, and S1F). We used the PH domain 
of DydA in a lipid-binding assay and found that it predominantly 
binds phosphatidylinositol 3-phosphate (PI(3)P), a phospholipid 
predominantly found in endosomes and phagosomes, but not 
PI(3,4)P2 or PI(3,4,5)P3, products of class I PI3Ks (Figure S1E). We 
also found that treatment of dydA− cells expressing GFP-DydA with 
the PI3K inhibitor LY294002 does not block GFP-DydA recruitment 
to the plasma membrane, indicating that PI3K is not required for the 
recruitment to the plasma membrane (unpublished data).
Interestingly, the stimulus-dependent cortical translocation of 
DydA was delayed and reduced in the absence of both CH domains 
(dydA−/DydAΔCH1+2-GFP; Figure 3I), indicating a function of the 
CH domains in DydA’s cortical localization. The deletion of both CH 
domains causes defects during chemotaxis: in a steep gradient, the 
cells move with a slightly higher speed than wild-type cells, but they 
turn more often than wild-type cells, and we observed an increase in 
bifurcated pseudopodia (Figure S1C), a phenotype that has been re-
ported for mutants of the SCAR/WAVE complex (Blagg et al., 2003). 
dydA−/DydAΔCH1+2-HHF cells exhibit an extended F-actin first peak 
and an elevated second peak (Figure 3D). These cells also exhibit an 
elevated basal level of assembled MyoII and kinetics similar to those 
of dydA− cells (Figure 3E), suggesting the CH domains are important 
in modulating the levels of F-actin and assembled MyoII.
In addition to the CH domains, the PRM plays a role in the corti-
cal localization of DydA in response to a chemoattractant stimulus. 
activation of Ras and Rap1. Ras activation was quantitated using 
pull-down assays employing two Ras-binding domains (RBDs) with 
different binding specificities: the Raf1-RBD (RBDRaf1), which prefer-
entially binds RasG, RasD, and RasB, and the Byr2-RBD (RBDByr2), 
which preferentially binds RasC and, with a lower affinity, RasG (Kae 
et al., 2004; Zhang et al., 2008). As previously reported (Kae et al., 
2004; Sasaki et al., 2004; Zhang et al., 2008; Charest et al., 2010), 
using RBDRaf1, we found that wild-type cells exhibit a low basal level 
of Ras-GTP, which rises rapidly in response to chemoattractant stim-
ulation with a peak at ∼5 s and then returns quickly to basal levels. 
In contrast, the activity measured using RBDByr peaks at ∼10 s 
(Figure 2F). This difference in the observed Ras activation kinetics in 
wild-type cells using the RBDRaf1 versus the RBDByr2 probe is consis-
tent with previous findings that RasG activation peaks at ∼5 s, 
whereas RasC peaks at ∼10 s (Kae et al., 2004; Sasaki et al., 2004; 
Zhang et al., 2008). Surprisingly, in dydA− cells, Ras activation using 
the RBDRaf1 probe is not increased, but is slightly decreased and 
delayed (Figure 2F), suggesting that the cause for the greatly ex-
tended and elevated cortical localization of PHcrac is independent of 
the level of Ras activation. Ras activity as measured using RBDByr2 
is unaltered in dydA− cells compared with that in wild-type cells. 
Similarly, we found chemoattractant-mediated Rap1 activation to 
be unaltered in these cells (Figure S1B).
To determine whether the DydA RA domains bind Ras and/or 
Rap1, similar to RA domains of other MRL members (Lafuente 
et al., 2004), we expressed RA1 and RA2 as GFP fusions in wild-
type cells and used the glutathione S-transferase (GST) fusions of 
the GDP and GTP forms of RasG, RasC, and Rap1 (RapA), and 
found that GFP-RA1 was only pulled down by RasG-GTPγS from 
Dictyostelium cell lysates (Figure 3A). We also did not observe 
binding of the activated form of Rap1 with a DydA fragment con-
taining RA1 and the adjacent PH domain (unpublished data). None 
of the Ras proteins pulled down GFP-RA2. We also examined the 
ability of the activated (GppNHp-bound) form of recombinant 
GST-RasC, -RasG, -RasD, which is closely related to RasG, and 
-Rap1 to bind recombinant RA1 and RA2 and found that only 
RasG- GppNHp and RasD-GppNHp showed any detectable bind-
ing (Figure S1C). Finally, we examined the ability of recombinant 
RA1 to stimulate the dissociation of mGppNHp from RasG, an as-
say of RA1 binding to RasG-GTP. In agreement with our other data 
indicating RasG-GTP binds RA1, we show that RA1 has GDI activity 
by demonstrating that addition of RA1 inhibits the dissociation of 
2′/3′-O-(N-Methylanthraniloyl)-guanosine-5′-[(β,γ)-imido]triphos-
phate (mGppNHP) from RasG and that the inhibition depends 
upon the concentration of RA1 (Figure S1D). As RasG is expressed 
throughout growth and aggregation, and RasD is preferentially ex-
pressed during multicellular development (Reymond et al., 1984; 
Robbins et al., 1989), we suggest that RasG is the major Ras pro-
tein that binds to DydA through RA1. We cannot exclude that an-
other Ras protein we have not tested may interact with either RA 
domain.
To further understand the role of the two RA domains, we exam-
ined the phenotypes of dydA− cells expressing His-hemagglutinin-
FLAG (HHF)-tagged DydA lacking both RA domains (DydAΔRA1+2-
HHF) and found that the cells exhibit strong chemotactic phenotypes, 
indicating that the RA domains are required for DydA function. In a 
steep gradient emitted by a micropipette, the cells are less polar-
ized and move slightly more slowly than wild-type cells. In a shallow, 
linear gradient produced in a Dunn chamber (Zicha et al., 1991), the 
cells are unable to migrate and the phenotype is as severe as that 
observed for dydA− cells (Figure 3, B and C). When we analyzed the 
profile of F-actin polymerization and MyoII assembly in dydA− cells 
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GSK-3β. The in vitro kinase assay, together with the phosphopro-
teomic findings, suggests that DydA is a direct target for GSK-3 in 
vivo. Interestingly, we observed some phosphorylation of DydA in 
gskA− cells (Figure 4, C and D). The phosphorylation occurs to a very 
small extent in the GSK-3 consensus motif, but mainly on adjacent 
Ser/Thr residues (see Discussion).
To examine the importance of phosphorylation by GSK-3 for the 
function of DydA, we expressed the nonphosphorylatable form of 
Daydreamer (DydAS861A/T865A-HHF) in dydA− cells. In a steep chemot-
actic gradient, these cells migrate more slowly than wild-type cells, 
but the defects are less severe than in the dydA− cells (Figure 4E). 
However, in a shallow, linear gradient, these cells do not migrate at 
all and the defects are as strong as those of dydA− cells (Figure 4F), 
indicating that phosphorylation of DydA by GSK-3 plays an impor-
tant role for the function of DydA during chemotaxis. Like dydA− 
cells, dydA− cells expressing DydAS861A/T865A-HHF exhibit increased 
MyoII assembly upon chemoattractant stimulation (Figure 3E). The 
elevated and extended phosphorylation of the AL and HM motifs 
of Akt/PKB and PKBR1 exhibited by dydA− cells is only partially 
suppressed by expressing DydAS861A/T865A-HHF, while the elevated 
F-actin response is fully suppressed (Figures 3, D, F, and G, and S1A). 
These observations suggest that some, but not all, functions of Day-
dreamer require phosphorylation by GSK-3. We tried to generate a 
phosphomimic version of DydA by mutating Ser861 to Glu and Thr865 
to Asp. Expression of DydAS861E/T865D-HHF in dydA− cells does not 
complement dydA− phenotypes but produces dominant effects: 
wild-type as well as dydA− cells expressing DydAS861E/T865D exhibit 
deeply reduced speed and lower directionality (unpublished data).
gskA− cells exhibit strong chemotactic defects
As DydA requires phosphorylation by GSK-3 for full function, we 
wanted to understand the role of GSK-3 in context with GSK-3’s 
overall role in chemotaxis. To this end, we conducted an analysis of 
the phenotype of gskA− cells similar to that which we performed on 
dydA− cells. Consistent with previously reported observations, we 
found that gskA− cells exhibit strong chemotactic defects (Teo et al., 
2010; Kim et al., 2011; Figure 5, A and B, and Movies S4 and S5). 
The cells are less polarized, show a reduced speed compared with 
wild-type cells, lack directionality in their migration, and move al-
most randomly in a chemoattractant gradient emitted by a micropi-
pette. These defects are more severe than those of dydA− cells. 
During development, gskA− cells form small aggregates through 
random collision and adhesion rather than directed migration to-
ward each other (Figure S2A). The migration parameters of devel-
oped, “aggregation-competent” gskA− cells migrating in a chemoat-
tractant gradient are similar to those of cells moving randomly in the 
absence of a chemoattractant gradient (Figure 5A), suggesting that 
GSK-3 has an important role in gradient sensing rather than cell 
motility and/or linking directional sensing with persistent, localized 
F-actin polymerization at the site on the cortex closest to the 
chemoattractant source. In addition, the analysis of random move-
ment of vegetative cells demonstrates that gskA− vegetative cells 
move faster than wild-type cells (Figure 5C), suggesting that the lack 
of efficient chemotaxis of gskA− cells is not due to defects in 
motility.
The level of F-actin polymerization in gskA− cells is similar to that 
of wild-type cells, but the first peak decreases faster than in wild-type 
cells (Figure 5D). However, the level of MyoII assembly upon chemoat-
tractant stimulation is reduced dramatically in gskA− cells (Figure 5E). 
Interestingly, the rapid decrease of the first peak of F-actin and the 
dramatic reduction in MyoII assembly are also observed in dydA− 
cells expressing DydAΔRA1+2-HHF. Because MyoII assembly is 
DydAΔPRM-GFP shows reduced localization to the cortex in 
response to chemoattractant stimulation, and dydA− cells express-
ing DydAΔPRM-HHF show reduced migration speed (Figures 3I and 
S1C); a deletion of the CH domains together with the PRM domain 
further reduces the localization of the protein to the cortex and the 
leading edge (Figure 3I), indicating that these domains contribute 
to the localization of DydA to the leading edge but are not solely 
responsible for DydA’s subcellular localization. The PRM from the 
mammalian MRL member lamellipodin binds VASP, which is re-
quired for lamellipodin function. We tested whether the DydA PRM 
binds to Dictyostelium VASP in a pull-down assay and were unable 
to detect any binding (unpublished data). Furthermore, unlike the 
PRM of lamellipodin, which has a sequence context similar to that of 
other VASP-binding PRM domains, the sequence of the DydA PRM 
does not. Taken together, our findings indicate that the CH and PRM 
domains, but not the PH domain, contribute to the localization of 
DydA to the leading edge of chemotaxing cells and are important 
for the function of DydA in regulating the cytoskeleton.
GSK-3 phosphorylates DydA and is required for some, 
but not all, DydA functions
We previously reported using total-cell phosphoproteomic analysis 
of unstimulated (0 s, basal) cells and cells stimulated for 10 s (the 
time of maximum activation of many leading-edge pathways) and 
60 s (adaptation) to identify proteins that are differentially phospho-
rylated in response to chemoattractant stimulation (Charest et al., 
2010). These phosphoproteomic data indicated that in wild-type 
cells, DydA is constitutively phosphorylated at Ser860/861 and Thr865, 
which lie between the PRM and the C-terminal RA2 domain (Figure 
1A; unpublished data). Treatment of DydA-HHF purified from dydA− 
cells with λ-protein phosphatase results in an increase in DydA-HHF 
mobility on SDS gels, consistent with the protein being phosphory-
lated (Figure 4A).
The identified phosphorylation site in DydA matches the GSK-3 
consensus motif Ser/Thr-(X-X-X)-pSer/pThr, with X being any amino 
acid (Figure 4B). GSK-3 has a unique substrate specificity wherein, 
for efficient phosphorylation by GSK-3, many substrates require a 
Ser/Thr priming phosphorylation at a site located four residues C-
terminal to the site of GSK-3 phosphorylation, with both the priming 
phosphorylation and the phosphorylation by GSK-3 often being Pro-
directed (Ser/Thr-(Pro-X-X)-pSer/pThr-Pro; Frame et al., 2001). As 
the DydA phosphorylation site conforms to a GSK-3 consensus site 
with both sites followed by a Pro (Figure 4B), we repeated the whole-
cell phosphoproteomic analysis of wild-type cells and, at the same 
time, cells lacking GSK-3 (gskA− cells) before and at 10 and 60 s after 
chemoattractant stimulation. When compared with wild-type cells, 
the phosphorylation of DydA at the GSK-3 site in gskA− cells is dra-
matically reduced, which is consistent with a decrease in the mobility 
of DydA-HHF purified from gskA− cells compared with that from 
dydA− cells (wild-type for gskA) on SDS gels (Figure 4, C and D).
To verify that DydA is a direct target of GSK-3, we expressed 
DydA-HHF in gskA− cells, immunoprecipitated the tagged protein, 
and used it in an in vitro kinase assay with recombinant human GSK-
3β. Figure 4D illustrates that DydA can be directly phosphorylated 
by GSK-3β in vitro. Phosphorylation data on DydA carrying Ala mu-
tations of Ser860 or Ser861 together with Thr865 indicate that Ser861 is 
the residue that is preferentially phosphorylated by GSK-3β, which 
is consistent with the consensus site for GSK-3 (Figure 4D). Unex-
pectedly, DydA-HHF in which three Ser residues (Ser859–861) are mu-
tated to Ala exhibits moderate phosphorylation (Figure 4D). A pos-
sible explanation for this observation might be that these mutations 
lead to changes that make the adjacent Ser highly accessible for 
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FIGURE 3: Role of the DydA domains in controlling DydA function. (A) Pull down in Dictyostelium lysate with the 
indicated inactive (GDP) or active (GTP) bound GST-GTPase as bait and GFP-DydRA1 as prey. The amount of prey 
and bait (bottom panel) were detected by Western blotting using antibody specific for GFP or GST, respectively. 
(B and C) DIAS analysis of chemotaxis of dydA− and wild-type cells in response to a chemoattractant gradient produced 
by a micropipette (B) or in a Dunn chamber (C). Data represent mean ± SD; speed indicates the speed of the cells’ 
centroid movement along the total path; directionality indicates the linearity of the migration paths; direction change is 
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localization of the PI(3,4,5)P3-responsive reporter PHcrac-GFP. Unex-
pectedly, we found that PHcrac-GFP has a deeply reduced level of 
chemoattractant-stimulated membrane localization in gskA− com-
pared with wild-type cells, but with the peak level remaining for a 
more extended time than that in wild-type cells (Figure 6E; Teo et al., 
2010). When we examined the kinetics of extent of chemoattractant-
stimulated PI3K cortical localization using GFP-PI3Kloc (a PI3K local-
ization reporter, rather than full-length PI3K, which leads to elevated 
PI(3,4,5)P3 levels and aberrant phenotypes [Funamoto et al., 2002]), 
we found that, like the PI(3,4,5)P3 levels assayed using PHcrac-GFP, 
the proportion of PI3K that localized to the cortex was reduced, and 
the kinetics were extended (Figure 6F). These results indicate that 
changes in the phosphorylation of Akt/PKB in gskA− cannot be ex-
plained by increases in PI(3,4,5)P3 levels or PI3K activity.
DISCUSSION
Role of DydA in regulating chemotaxis
We have identified DydA, a new member of the MRL family of adap-
tor proteins, and show that it is required for multiple regulatory 
pathways that control directional sensing and cell motility. dydA− 
cells move more slowly than wild-type cells in a steep chemoattrac-
tant gradient and with a significant reduction in directionality com-
pared with that of wild-type cells. Thus DydA is required for both 
cell motility and directional sensing. In response to chemoattractant 
stimulation, a number of signaling pathways are activated normally 
in dydA− cells, indicating that the cells are not generally deficient in 
responding to chemoattractant. We suggest that DydA is required 
to efficiently amplify the chemoattractant gradient, as the cells ex-
hibit significantly more severe defects in shallow than steep gradi-
ents. Because DydA is required for multiple chemotactic pathways, 
binds RasG-GTP via a domain required for its functions, and requires 
phosphorylation by GSK-3 for full function, we propose that DydA 
helps integrate the function of several signaling pathways to regu-
late cell polarity and chemotaxis.
The DydA RA1 domain binds RasG-GTP, but not RasC-GTP (an-
other Ras required for chemotaxis in Dictyostelium), and DydA lack-
ing RA1/2 is unable to complement dydA− phenotypes and results 
in dominant-negative phenotypes when expressed in wild-type 
cells. We are unable to test, and therefore directly demonstrate, that 
RasG activation is required for DydA, because of the strong pheno-
types of rasG– and RasG-gain-of-function strains. However, as Ras 
activation is not greatly altered in dydA− cells, we suggest that DydA 
lies downstream of RasG-GTP. This result, combined with the re-
quirement of the RA domains, is consistent with a model that DydA 
plays a key role in regulating RasG-mediated polarity and direction-
ality. Furthermore, consistent with DydA’s role in directional sensing, 
DydA localizes to the leading edge of migrating cells and rapidly 
and transiently to the cell cortex in response to chemoattractant 
stimulation in a process that requires, in part, the CH domains and 
the PRM. Although the RA domains are required for DydA function, 
they are not required to localize DydA to the cortex but may nega-
tively modulate DydA cortical binding as DydA lacking these 
regulated by Rap1 (Kortholt et al., 2006; Jeon et al., 2007), we ana-
lyzed the activation of Rap1 using RBDRalGDS in pull-down assays and 
observed a slight increase in the basal level of activated Rap1 and a 
slightly lower level of Rap1 activation on stimulation in gskA− cells 
compared with wild-type cells (Figure S2B). But these slight differ-
ences cannot account for the dramatic reduction of MyoII assembly 
observed in the gskA− cells. This indicates that GSK-3 affects MyoII 
assembly mainly downstream from or independent of Rap1, possibly 
through DydA, which also regulated MyoII assembly.
Because of the strong directionality defects exhibited by gskA− 
cells, we examined the activity of Ras using the two RBDs with differ-
ent binding specificities, RBDRaf1 and RBDByr2, as described for 
DydA. Compared with wild-type cells, the kinetics of Ras activation 
using RBDRaf1 are delayed and extended in gskA− cells, with a 
broader peak centering at 10–20 s and with high levels of Ras-GTP 
still present at 30 s (Figure 6A). In contrast, when using RBDByr2, we 
found that the basal level of Ras-GTP was highly elevated and in-
creased only slightly upon stimulation to the wild-type level and 
then decreased slowly to the high basal level observed in unstimu-
lated gskA− cells, indicating a misregulation of Ras levels and kinet-
ics in gskA− cells. This is in sharp contrast to dydA− cells, which show 
almost normal Ras regulation.
As discussed in the DydA Ras analysis, of the tested Ras proteins, 
RasC-GTP preferentially binds to RBDByr2, suggesting the elevated 
Ras-GTP levels assayed using the RBDByr2 probe are due to elevated 
RasC-GTP. We tested this directly by expressing epitope-tagged 
RasC in wild-type and gskA− cells and assaying the kinetics and rela-
tive levels of RasC-GTP. Unexpectedly, we found that the normal-
ized level of RasC activation was slightly lower in gskA− compared 
with that in wild-type cells. We suggest that the elevated Ras activa-
tion assayed by the RBDByr2 probe is a different Ras and one that has 
not been previously characterized.
Because the kinetics of Ras activation in gskA− cells are highly 
aberrant, we investigated two known Ras effectors, TORC2 and 
PI3K, by analyzing the phosphorylation of the HM and AL of Akt/
PKB and PKBR1. Compared with our observations in wild-type cells, 
both Akt/PKB and PKBR1 have a delayed peak and extended kinet-
ics of HM phosphorylation in gskA− cells (Figures 6B and S2C). The 
phosphorylation of the AL is extended in Akt/PKB and PKBR1, with 
the effect being most pronounced on the Akt/PKB AL (Figures 6B 
and S2C). Akt/PKB shows a highly increased basal phosphorylation 
of the AL. We see a corresponding higher basal activity for the Akt/
PKB kinase and greatly extended chemoattractant-mediated activa-
tion of Akt/PKB and PKBR1 kinase activity (Figure 6, C and D). These 
findings are in conflict with the results of Teo et al. (2010), who ob-
served no phosphorylation of the AL of Akt/PKB and PKBR1 in 
gskA− cells. Our observations suggest that the regulation of Ras, 
Akt/PKB, and PKBR1 is highly aberrant in gskA− cells.
To determine whether the highly extended phosphorylation of 
the Akt/PKB AL is the result of elevated PI3K activity, which could 
result in an extended localization of Akt/PKB at the plasma mem-
brane, we examined the kinetics and extent of plasma membrane 
a relative measure of the number and frequency of turns of the cells; roundness is a measure of the polarization of the 
cells. (D and E) cAMP-induced F-actin polymerization (D) and MyoII assembly (E). Data represent mean ± SE of at least 
three independent experiments, with the starting condition in wild-type cells taken as 1.0. (F and G) Phosphorylation 
of the HM and AL of Akt/PKB and PKBR1, respectively, in dydA− cells expressing DydAΔRA1+2-HHF or 
DydAS861A/T865A–HHF in response to cAMP. Coomassie Blue staining was used as loading control. Quantification of 
normalized HM and AL phosphorylation of Akt/PKB and PKBR1 can be found in Figure S1A. (H) Localization of 
DydAΔPH-GFP at the leading edge. (I) Translocation kinetics of DydA-GFP carrying different deletions in response to 
cAMP stimulation. The data represent the mean ± SE of relative fluorescence intensity of membrane-localized DydA-
GFP as a function of time after cAMP stimulation with the starting condition taken as 1.0.
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FIGURE 4: Phosphorylation of DydA by GSK-3. (A) Phosphatase treatment of DydA-HHF. Phosphorylation of DydA 
from dydA− cells was determined in the presence or absence of λ–protein-phosphatase. (B) Phosphorylation site of 
DydA and the GSK3 consensus motif. (C) Phosphoproteomic data of DydA in wild-type and gskA− cells. Phosphorylation 
occurs in three different clusters of Ser/Thr. (D) In vitro kinase assay with DydA-HHF. Phosphorylation of DydA-HHF and 
DydA-HHF carrying Ala mutations in the GSK-3 consensus motif purified from gskA− cells was examined in the presence 
and absence of GSK-3β. (E and F) DIAS analysis of chemotaxis of dydA−/DydAS861A/T865A-HHF and control cells in 
response to a chemoattractant gradient produced by a micropipette (E) or in a Dunn chamber (F). Data represent mean 
± SD; speed indicates the speed of the cells’ centroid movement along the total path; directionality indicates the 
linearity of the migration paths; direction change is a relative measure of the number and frequency of turns of the cells; 
roundness is a measure of the polarization of the cells.
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polymerization, although we have not demonstrated that this is a 
direct effect. This is in contrast to the MRL protein lamellipodin, 
which stimulates F-actin polymerization at the leading edge through 
the recruitment of VASP. We also found that the basal levels of MyoII 
are elevated in dydA− cells. A direct role for DydA in F-actin polym-
erization and MyoII assembly downstream of Ras family GTPases is 
also supported by the considerable inhibition of both responses in 
dydA− cells expressing DydAΔRA1+2. We suggest that DydAΔRA1+2 
acts as an active form of DydA, binds to and blocks the function of 
DydA effectors, and inhibits the regulation of F-actin assembly and/
or promotes faster F-actin depolymerization.
domains exhibits a highly elevated cortical binding. We also ob-
served an extended phosphorylation of the ALs of AKT/PKB and 
PKBR1, which is consistent with the extended activity of PI3K based 
on PH-domain localization studies. However, the relative levels and 
kinetics of chemoattractant-mediated kinase activity are only slightly 
extended compared with wild-type cells.
Our analyses indicate that DydA is required for the regulation of 
the cytoskeleton. dydA− cells exhibit a highly elevated first and sec-
ond peak of F-actin assembly. As the basal level of F-actin is similar 
to that seen in wild-type cells, we suggest that DydA functions to 
negatively regulate the extent of chemoattractant-mediated F-actin 
FIGURE 5: gskA− cells exhibit severe chemotactic defects. (A) DIAS analysis of chemotaxing and randomly moving 
aggregation-competent wild-type and gskA− cells. Data represent mean ± SD; speed indicates the speed of the cells’ 
centroid movement along the total path; directionality indicates the linearity of the migration paths; direction change is 
a relative measure of the number and frequency of turns of the cells; roundness is a measure of the polarization of the 
cells. (B) Trajectories of cells moving toward cAMP. The plot represents the angle between the start and the end point of 
a cell relative to the chemoattractant gradient, represented by the vertical line. (C) DIAS analysis of randomly moving 
vegetative cells. Data represent mean ± SD; speed indicates the speed of the cells’ centroid movement along the total 
path; directionality indicates the linearity of the migration paths; direction change is a relative measure of the number 
and frequency of turns of the cells; roundness is a measure of the polarization of the cells. (D and E) cAMP-induced 
F-actin polymerization and MyoII assembly, respectively, in gskA− cells. Data represent the mean ± SE of at least three 
independent experiments, with the starting condition in wild-type cells taken as 1.0.
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FIGURE 6: Regulation of effector pathways by GSK-3. (A) Ras activation in gskA− cells. cAMP-induced Ras activation 
was assessed using RBDRaf1 and RBDByr2 in pull-down assays. Levels of total Ras and Ras-GTP were detected by 
immunoblotting with an anti–pan-Ras antibody and quantified, with the maximum value of wild-type cells was taken as 
1.0; data are mean ± SD of at least three independent experiments. (B) Phosphorylation of the HM and AL of Akt/PKB 
and PKBR1 in wild-type and gskA− cells in response to cAMP. Coomassie Blue staining was used as loading control. 
(C and D) cAMP-induced Akt/PKB and PKBR1 kinase activity, respectively. H2B was used as substrate; Akt/PKB and 
PKBR1 protein levels were determined by immunoblotting; for quantification, the maximum value of wild-type cells 
was taken as 1.0; data are mean ± SE of at least three independent experiments. (E and F) Translocation kinetics of 
PHcrac-GFP (E) and N-termPI3K-GFP (a reporter for PI3K localization) (F) in wild-type and gskA− cells in response 
to cAMP stimulation. The data represent the mean ± SE of relative fluorescence intensity of membrane-localized 
PHcrac-GFP and PI3K-GFP as a function of time after cAMP stimulation with the starting condition taken as 1.0.
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DydA function requires GSK-3
Through in vitro and in vivo studies, we verified DydA as a direct 
target of GSK-3 and show that this phosphorylation is required for 
many of DydA’s functions. As the nonphosphorylatable form of 
DydA complements some DydA functions and localizes to the cell 
cortex and appears stable, we do not believe the mutant protein is 
misfolded. Our data indicate that DydA affects multiple functions 
required for chemotaxis. On the one hand, it is regulating F-actin 
polymerization, which seems to be independent of the GSK-3 phos-
phorylation. On the other hand, DydA is negatively regulating MyoII 
assembly, a function that is dependent of the phosphorylation by 
GSK-3.
We observed a small amount of phosphorylation of the GSK-3 
site of DydA, even in the absence of GSK-3, and at Ser/Thr residues 
adjacent to the GSK-3 consensus site. We do not know whether this 
phosphorylation of DydA in the absence of GSK-3 has any biologi-
cal relevance, because this phosphorylation appears only in the ab-
sence of GSK-3 and our data indicate that under normal conditions, 
DydA is constitutively phosphorylated, presumably by GSK-3 and a 
priming kinase. The absence of GSK-3 might make this site acces-
sible to other kinases, resulting in some phosphorylation at sites 
independent of the GSK-3 consensus site. In addition, there is a 
GSK-3–like kinase in Dictyostelium encoded by the glkA gene 
(DDB_G0270218; Goldberg et al., 2006) that might be responsible 
for the residual phosphorylation in the absence of GSK-3. We do not 
know whether GlkA is expressed at aggregation stage or whether it 
acts as a functional kinase recognizing the same consensus site as 
GSK-3. The stimulus-independent, constitutive phosphorylation of 
DydA supports the role of GSK-3 as a permissive signal as proposed 
by Teo et al. (2010). However, we cannot exclude the possibility that 
DydA phosphorylation is dynamically regulated with a rapid cycle of 
phosphorylation/dephosphorylation.
GSK-3 is a major regulator of chemotaxis in Dictyostelium
Little was understood about the function of GSK-3 in chemotaxis in 
Dictyostelium. Our study uncovered a new component of the GSK-3 
regulatory network that helps mediate chemotaxis. Previous studies 
had demonstrated that gskA− cells have highly aberrant chemotaxis, 
and one suggested this was due to a loss of PI3K regulation and 
could be suppressed by overexpression of inositol monophos-
phatase (IMP-A), which increases PI(3,4,5)P3 by increasing the levels 
of the PI3K substrate PI(4,5,)P2 (Teo et al., 2010). As increased 
PI(3,4,5)P3 can cause gain-of-function phenotypes, it is possible that 
the suppression of the gskA− chemotactic phenotype by IMP-A may 
be indirect. Others’ findings and our own suggest that PI(3,4,5)P3 
levels are reduced two- to threefold based on PH-domain localiza-
tion studies (Teo et al., 2010). However, as loss of PI3K has only 
modest effects on chemotaxis in step gradients (Funamoto et al., 
2002; Hoeller and Kay, 2007; Takeda et al., 2007; Veltman et al., 
2008), it is unlikely that decreased PIP3 results in the severe 
gskA− phenotypes.
We provide evidence that Ras activity is highly aberrant in gskA− 
cells, suggesting a basis for the severe defects in directional sensing 
observed in the gskA− cells. The high basal Ras activity measured 
using the RBDByr might be due to an up-regulation of basal RasC 
activity. The RasC effector TORC2 was thought to be inactive in the 
gskA− cells (Teo et al., 2010), but in our hands, TORC2 was activated 
in the absence of GSK-3 and strongly phosphorylated the HM of 
Akt/PKB and PKBR1. This is thought to be a prerequisite for the 
AL phosphorylation mediated by the two PDK1 isoforms, PdkA 
and PdkB (Kamimura et al., 2008; Liao et al., 2010). PdkA mainly 
phosphorylates the AL of Akt/PKB and only partially affects PKBR1 
phosphorylation, whereas PdkB exclusively phosphorylates the AL 
of PKBR1. Kimimura and Devreotes (2010) demonstrated that tran-
sient PdkA activation is independent of PI(3,4,5)P3 and TORC2, but 
that RasC may directly affect PdkA activity (Kamimura and 
Devreotes, 2010). Therefore increased RasC activity in the gskA− 
cells might lead to increased PdkA activity and higher phosphoryla-
tion of the AL of Akt/PKB and higher Akt/PKB activity. Because the 
AL of PKBR1 is also phosphorylated by PdkB, effects are less promi-
nent for PKBR1 AL phosphorylation. At this point, we do not know 
how GSK-3 might affect RasC activity. It was unexpected that the 
highly increased and extended activity of Akt/PKB and PKBR1 in 
gskA− cells did not lead to severe changes in F-actin polymerization. 
It might be possible that the dramatic decrease in PI(3,4,5)P3 coun-
terbalances the effects of increased Akt/PKB and PKBR1 activity on 
F-actin polymerization.
Our findings that cells expressing the nonphosphorylatable form 
of DydA exhibit extended AL and HM phosphorylation suggest that 
DydA might mediate, in part, GSK-3’s role in the regulation of the 
phosphorylation of PKB and PKBR1. In addition, the effect of GSK-3 
on MyoII assembly might be mediated through DydA, since DydA 
lacking both RA domains exhibits a similar defect in MyoII assembly. 
It is clear that the phenotype of gskA− cells is complex, and GSK-3 
most likely functions through a number of substrates, including 
DydA, as part of a larger network that controls chemotaxis. Our phos-
phoproteomic analysis suggests additional substrates for GSK-3. 
However, additional biochemical and genetic analyses will be re-
quired to demonstrate these are bona fide GSK-3 substrates and that 
phosphorylation by GSK-3 is required for their function.
MATERIALS AND METHODS
Cell culture
Cells were grown in axenic HL5 medium at 22°C. For the expression 
of GFP- or epitope-tagged proteins, 20 μg/ml Geneticin (Gibco, 
Grand Island, NY) was added. Knockout cell lines were selected 
with 7.5 μg/ml blasticidin S. For obtaining aggregation-competent 
cells, log-phase vegetative cells were washed with 12 mM Na/K 
phosphate buffer, resuspended at 5 × 106 cells/ml in 12 mM Na/K 
phosphate buffer, and pulsed with 30 nM cAMP at 6-min intervals 
for 5.5 h. Aggregation-competent cells were used for the assays un-
less otherwise indicated.
Strains and constructs
Ax-2 or KAx-3 were used as wild-type. gskA− cells were obtained 
from the Dictyostelium Stock Center. We confirmed that these were 
gskA− cells by Southern analysis. We also did not identify any GskA 
peptides identified in wild-type cells in the gskA− strain using mass 
spectrometry, confirming that the protein was not present at detect-
able levels (unpublished data). We also tested the gskA− strain for 
the expression of two aggregation genes (encoding the phosphodi-
esterase [PDE] psdA and the adenylyl cyclase AcaA) under our con-
ditions used to study gskA− cells (5.5. h cAMP pulsing), which were 
found previously to be poorly expressed in gskA− cells plated for 
development compared with wild-type cells (Teo et al., 2010). We 
found that AcaA exhibited normal expression, while psdA expres-
sion was not normal (Figure S2D). We assume the difference be-
tween our results and those of Teo et al. (2010) are due to different 
conditions of development between the experiments reported here 
and those of Teo et al. (2010).
Gene disruption for DydA was performed by insertion of a blas-
ticidin-S resistance cassette at base pair 561. Clones were selected 
in the presence of blasticidin S, and gene disruption was confirmed 
by PCR and Southern blotting. DydA was cloned from cDNA 
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(3636 base pairs). Deletion constructs and constructs carrying point 
mutations for DydA were generated using QuikChange site-directed 
mutagenesis (Stratagene, Agilent, Santa Clara, CA). For DydA, the 
following deletions were generated:
DydAΔRA1 + 2: deletion of base pairs 13–270 + 3334–3558 (aa 
5–90 + 1112–1196)
DydAΔPH: deletion of base pairs 397–675 (aa 133–225)
DydAΔCH1 + 2: deletion of base pairs 835–1500 (aa 279–500)
DydAΔPRM: deletion of base pairs 1756–2106 (aa 586–702)
GFP- or His-HA-FLAG (HHF) epitope-tagged versions of Day-
dreamer were generated in Exp-4 (obtained from the Dictyostelium 
Stock Center) carrying 3′ tags for GFP or HHF. GST-DydA1-798 
(aa 1–266) and the constructs for the yeast two-hybrid system were 
generated using Gateway Cloning (Invitrogen, Carlsbad, CA), with 
pDEST21 as the entry vector and pDEST15 or pDEST22 and 
pDEST32 as the expression vector(s).
Chemotaxis and cell motility
Chemotactic analysis, the analysis of the global response to a 
chemoattractant, and vegetative cell motility analysis were per-
formed as previously described (Chung and Firtel, 1999; Sasaki 
et al., 2007; Wessels et al., 1998; Zhang et al., 2008).
Coimmunoprecipitation
Log-phase vegetative cells (1 × 108) were washed with 12 mM Na/K 
phosphate buffer and lysed in lysis buffer (50 mM HEPES, pH 8, 
150 mM NaCl, 0.5% Triton-X100, 10% glycerol, protease inhibitors, 
phosphatase inhibitors) for 1 h at 4°C. For coimmunoprecipitation 
after stimulation, aggregation-competent cells were stimulated with 
1 μM cAMP, different time points were collected, and the cells were 
lysed in lysis buffer for 1 h at 4°C on a rotator. After centrifugation, 
the supernatant was incubated with 40 μl of 50% FLAG-agarose 
beads (Sigma-Aldrich, St. Louis, MO) for 1 h at 4°C on a rotator. The 
beads were washed three times with lysis buffer and used for kinase 
assays or phosphatase treatment.
Phosphatase treatment
After coimmiunoprecipitation, the beads were washed once in 
lysis buffer without phosphatase inhibitors and once in phos-
phatase buffer and then incubated with 800 U λ-protein phos-
phatase (NEB, Ipswich, MA) for 30 min at 37°C. The beads were 
resuspended in SDS-sample buffer and separated on SDS–
PAGE, and the protein was detected with α-FLAG M2 antibody 
(Sigma-Aldrich).
In vitro kinase assay
After coimmunoprecipitation, the beads were washed once in 
kinase buffer (5 mM MOPS, pH 7.2, 2.5 mM β-glycerophosphate, 
1 mM ethylene glycol tetraacetic acid (EGTA), 0.4 mM EDTA, 4 mM 
MgCl2, 0.05 mM dithiothreitol [DTT], 40 ng/μl bovine serum albu-
min) and then incubated with 100 ng human recombinant GSK-3β 
(Cell Signaling Technology, Danvers, MA) in the presence of radio-
actively labeled ATP (250 μM, 2 μCi/ μl) for 20 min at room tempera-
ture. All liquid was removed, the beads were resuspended in SDS-
sample buffer, and the proteins were separated on SDS–PAGE. The 
signals were detected by autoradiography.
Ras and Rap1 activity assays
Ras activity assays were performed as previously described (Sasaki 
et al., 2004; Zhang et al., 2008). Rap1 activity assays were performed 
as described previously (Jeon et al., 2007). The experiment was re-
peated at least three times on separate days with internal wild-type 
controls. The Western blots were quantified using ImageJ.
F-actin polymerization and MyoII assembly
Log-phase vegetative cells were washed with 12 mM Na/K phos-
phate buffer and resuspended at 5 × 106 cells/ml in 12 mM Na/K 
phosphate buffer. The cells were starved for 1 h and then pulsed 
with 30 nM cAMP at 6-min intervals for 4.5 h. The cells were washed 
once with 12 mM Na/K phosphate buffer and incubated for 30 min 
before stimulation. After cells were stimulated with 1 μM cAMP, dif-
ferent time points were collected, and cytoskeletal proteins were 
isolated as described previously (Steimle et al., 2001). The samples 
were separated on SDS–PAGE and stained with Coomassie Blue. 
Protein amounts were quantified using ImageJ. The experiment was 
repeated at least three times on separate days with internal wild-
type controls.
Phalloidin staining
Phalloidin staining was performed as described previously (Chung 
et al., 2000).
Akt/PKB kinase activity assay
Akt/PKB and PKBR1 kinase activities were performed and analyzed 
as described previously (Meili et al., 1999). H2B was used as a sub-
strate. The experiment was repeated at least 3 times on separate 
days with internal wild-type controls. The Western blots were quan-
tified using ImageJ.
PKB/PKBR1 phosphorylation
Aggregation-competent cells were stimulated with 1 μM cAMP. 
Different time points after stimulation were lysed in 2× SDS-sam-
ple buffer, and equal amounts of total protein were separated 
on SDS–PAGE. Phosphorylation of Akt/PKB and PKBR1 at the 
HM was detected using α-phospho-p70 S6 kinase antibody (Cell 
Signaling Technology, Danvers, MA), and phosphorylation at the 
AL was detected using α–phospho-protein kinase C (pan) anti-
body (Cell Signaling Technology; Kamimura et al., 2008). Coo-
massie Blue staining of total proteins was used as loading con-
trol. The experiment was repeated at least three times on 
separate days with internal wild-type controls. The Western 
blots were quantified using ImageJ.
Lipid-binding assay
GST-DydA1-798 and GST alone were expressed in bacteria and 
purified using glutathione-Sepharose 4B beads (GE Healthcare, 
Waukesha, WI) according to the manufacturer’s protocol. PIP strips 
from Echelon Biosciences (Salt Lake City, UT) were incubated 
with 0.5 μg/ml protein following the provided protocol. The GST 
proteins were detected using α-GST antibody (Cell Signaling 
Technology).
Pull-down experiments
N-terminal GFP-tagged DydRa1 and DydRA2 were expressed in 
Dictyostelium from the previously published pDM317 plasmid 
(Veltman et al., 2009). Cells were lysed by incubation in lysis buffer 
(10 mM Na2HPO4, pH 7.2, 1% Triton X-100, 10% glycerol, 150 mM 
NaCl, 10 mM MgCl2, 1 mM EDTA, 1 mM Na3VO4, 5 mM NaF, and 
protease inhibitor cocktail [Roche, Indianapolis, IN]) for 10 min on 
ice. Unsoluble proteins were spun down, and precleared lysate was 
used in pull down with different small G-protein samples. GST fusion 
of c-truncated small G proteins (RapA, RasC, and RasG) were 
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purified as described before (Kortholt et al., 2006). Proteins were 
loaded with nucleotides (GDP or GTPγS) by incubation for 1 h at 
room temperature with 100× excess of the given nucleotide (50 mM 
Tris, pH 7.5, 50 mM NaCl, 5 mM MgCl2, 10 mM EDTA, 5 mM DTT), 
and the reaction was stopped by adding MgCl2 to a final concentra-
tion of 20 mM. Proteins were prebound to GSH beads (GE Health-
care) for 1 h at 4°C, and unbound fraction was washed away with 
PBS. Beads were subsequently mixed with Dictyostelium cell lysates 
and incubated 4°C overnight with rotation. PBS washing steps were 
performed to wash away the unbound proteins, and beads were 
boiled in 1× SDS loading buffer. Prey and bait proteins were 
detected by means of Western blotting with GFP- or GST-specific 
antibodies (SC9996 [Santa Cruz Biotechnology, Santa Cruz, CA] or 
27-4577-01 [GE Healthcare]).
Protein purification and GDI assays
DydRA1 and DydRA2 were expressed from a pGEX4T1 plasmid 
containing an N-terminal GST and Tobacco Etch Virus (TEV) cleav-
age side. Proteins were isolated by glutathione affinity purifica-
tion, proteolytic cleavage, and size exclusion chromatography as 
previously described (Kortholt et al., 2006). The purified proteins 
were analyzed by SDS–PAGE, and the concentration was deter-
mined by Bradford’s method (Bio-Rad, Hercules, CA). The purified 
protein was used in a GDI assay as previously described (Kortholt 
et al., 2006).
Mass spectrometry and phosphopeptide analysis
For the phosphoproteomics assay, samples were prepared as previ-
ously described (Charest et al., 2010). Phosphopeptide analysis was 
performed as described previously (Para et al., 2008). Briefly, we 
lysed aggregation-competent Ax-2 and gskA− cells before and after 
stimulation with cAMP. After tryptic digestion, the phosphopep-
tides were enriched, and the samples were analyzed with liquid 
chromatography–tandem mass spectrometry. The raw data were 
searched against the sequences from dictyBase (Eichinger et al., 
2005) using Spectrum Mill software (Agilent Technologies, Inc. 
Santa Clara, CA).
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